Ido Wolf

8.3k total citations · 1 hit paper
158 papers, 4.2k citations indexed

About

Ido Wolf is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Ido Wolf has authored 158 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 38 papers in Genetics and 34 papers in Molecular Biology. Recurrent topics in Ido Wolf's work include Parathyroid Disorders and Treatments (22 papers), Genetic Syndromes and Imprinting (20 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Ido Wolf is often cited by papers focused on Parathyroid Disorders and Treatments (22 papers), Genetic Syndromes and Imprinting (20 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Ido Wolf collaborates with scholars based in Israel, United States and Germany. Ido Wolf's co-authors include Bella Kaufman, Tamar Rubinek, Hagai Ligumsky, Raphael Catane, Hannah Kanety, H. Phillip Koeffler, Beth Y. Karlan, Avraham Karasik, Barliz Waissengrin and Siegal Sadetzki and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Ido Wolf

139 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility

2013 403 citations Hagai Ligumsky, Ido Wolf et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ido Wolf	1.6k	1.5k	879	705	606	158	4.2k
Matteo Puntoni	1.8k 1.2×	1.7k 1.1×	668 0.8×	1.2k 1.7×	81 0.1×	139	4.8k
Gaurav Agarwal	1.4k 0.9×	594 0.4×	547 0.6×	869 1.2×	851 1.4×	250	4.9k
Xiaoyan Cai	731 0.5×	1.5k 1.0×	287 0.3×	518 0.7×	124 0.2×	140	5.2k
Mauro Gacci	611 0.4×	1.8k 1.2×	328 0.4×	274 0.4×	594 1.0×	267	8.5k
Aruna V. Krishnan	946 0.6×	1.1k 0.7×	1.5k 1.7×	519 0.7×	58 0.1×	58	5.3k
James L. Wade	4.3k 2.8×	1.3k 0.9×	1.4k 1.6×	1.3k 1.8×	91 0.2×	153	7.6k
Richard A. Prinz	2.5k 1.6×	1.2k 0.8×	513 0.6×	702 1.0×	828 1.4×	245	7.7k
Kimmie Ng	3.6k 2.3×	1.7k 1.2×	473 0.5×	1.1k 1.6×	56 0.1×	175	7.2k
Ali Shamseddine	2.3k 1.5×	1.6k 1.1×	360 0.4×	1.1k 1.5×	56 0.1×	249	5.6k
Jennifer S. Herrick	2.0k 1.3×	2.3k 1.6×	518 0.6×	1.7k 2.5×	65 0.1×	127	5.6k

Countries citing papers authored by Ido Wolf

Since Specialization

Citations

This map shows the geographic impact of Ido Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Wolf more than expected).

Fields of papers citing papers by Ido Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ido Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Wolf. The network helps show where Ido Wolf may publish in the future.

Co-authorship network of co-authors of Ido Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Ido Wolf. A scholar is included among the top collaborators of Ido Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ido Wolf. Ido Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raz, Yael, Uriel Katz, Ido Laskov, et al.. (2025). Cytoreductive surgery in advanced epithelial ovarian cancer: a real-world analysis guided by clinical variables, homologous recombination, and BRCA status. International Journal of Gynecological Cancer. 35(6). 101809–101809.

Brzezinski, Rafael Y., Barliz Waissengrin, Zach Rozenbaum, et al.. (2024). Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors. Cardio-Oncology. 10(1). 2–2. 20 indexed citations

Bar, Yael, Shlomit Strulov Shachar, Ahuva Weiss‐Meilik, et al.. (2024). The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer. The Breast. 77. 103777–103777. 1 indexed citations

Wolf, Ido, et al.. (2024). Body and mind and self-consciousness awareness workshops: Improving quality of life in patients with cancer.. Journal of Clinical Oncology. 42(16_suppl). e24081–e24081.

Golan, Talia, Ofer Purim, Danny Rosin, et al.. (2024). Multi-institutional validation survey on Belong.life's conversational artificial intelligence (AI) oncology mentor, "Dave.. Journal of Clinical Oncology. 42(16_suppl). e13596–e13596. 1 indexed citations

Katz, Uriel, et al.. (2024). GPT versus Resident Physicians — A Benchmark Based on Official Board Scores. NEJM AI. 1(5). 50 indexed citations

Ligumsky, Hagai, Sharon Amir, Tali Scherf, et al.. (2024). Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells. Medical Oncology. 41(6). 138–138. 3 indexed citations

Merenbakh-Lamin, Keren, et al.. (2024). Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer. Breast Cancer Research and Treatment. 209(2). 431–449. 1 indexed citations

Klausner, Joseph M., Yona Greenman, Naftali Stern, et al.. (2023). A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines. 11(2). 407–407. 3 indexed citations

10.

Merenbakh-Lamin, Keren, Hagai Ligumsky, Moshe Giladi, et al.. (2023). Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho. Oncogene. 43(5). 354–362. 3 indexed citations

11.

Keizman, Daniel, Moshe Frenkel, Avivit Peer, et al.. (2023). Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients. 15(16). 3533–3533. 6 indexed citations

12.

Hasson, Shira Peleg, Dov Hershkovitz, Yuval Raviv, et al.. (2022). Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers. 15(1). 218–218.

13.

Shamai, Sivan, Hana Strul, Guy Rosner, et al.. (2021). Abdominal Desmoid: Course, Severe Outcomes, and Unique Genetic Background in a Large Local Series. Cancers. 13(15). 3673–3673. 5 indexed citations

14.

Waissengrin, Barliz, et al.. (2021). Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors (vol 22, pg 581, 2021). The Lancet Oncology. 22(6). 2 indexed citations

15.

Merenbakh-Lamin, Keren, Anat Klein, Metsada Pasmanik‐Chor, et al.. (2019). Ligand-binding Domain–activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells. Clinical Cancer Research. 25(9). 2900–2914. 29 indexed citations

16.

Ligumsky, Hagai, Tamar Rubinek, Keren Merenbakh-Lamin, et al.. (2015). Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis. Molecular Cancer Research. 13(10). 1398–1407. 39 indexed citations

17.

Abramovitz, Lilach, Tamar Rubinek, Hagai Ligumsky, et al.. (2011). KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer. Clinical Cancer Research. 17(13). 4254–4266. 107 indexed citations

18.

Paluch–Shimon, Shani, Noa Ben-Baruch, Ido Wolf, et al.. (2009). Hormone Receptor Expression Is Associated With a Unique Pattern of Metastatic Spread and Increased Survival Among HER2-Overexpressing Breast Cancer Patients. American Journal of Clinical Oncology. 32(5). 504–508. 10 indexed citations

19.

Paluch–Shimon, Shani, Ido Wolf, Hadassah Goldberg, et al.. (2008). High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer. Acta Oncologica. 47(8). 1564–1569. 11 indexed citations

20.

Symon, Zvi, Tatiana Rabin, D. Alezra, et al.. (2006). 2133. International Journal of Radiation Oncology*Biology*Physics. 66(3). S284–S285. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact